Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001493152-14-001663
Filing Date
2014-05-21
Accepted
2014-05-21 06:07:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g.htm SC 13G 64677
  Complete submission text file 0001493152-14-001663.txt   65979
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Subject) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE
Type: SC 13G | Act: 34 | File No.: 005-81115 | Film No.: 14859526
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4852 SAINT ANDRES AVE. LA VERNE CA 91750
Business Address
Riggs Arthur (Filed by) CIK: 0001557190 (see all company filings)

Type: SC 13G